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1015-9584/Copyright ª 2015, Asian SuAbstract Background: Buccinator-based myomucosal flaps can be used as a lining in oral cav-
ity, pharyngeal, esophageal, and nasal reconstructions. Donor site morbidity is an important
factor in selecting a flap, therefore, it was decided that donor site morbidity of this type of
flap should be evaluated.
Method: In a retrospective study, patients for whom this flap had been used for oral, nasal, or
pharyngeal reconstruction in 2008e2012 were recalled. Donor site morbidity including reduc-
tion in maximal interincisal opening (MIO), obliteration of the mandibular vestibule, injury to
the Stensen duct, and vertical fibrous band in buccal mucosa were evaluated.
Results: Twenty-two buccinator-based myomucosal flaps (20 patients) had been used for oral,
nasal, or oropharyngeal reconstruction. The most common flap used was the Facial Artery Mus-
culomucosal (FAMM) flap (50%), and the commonest cause for flap use was the presence of a
cleft lip/palate sequel in patients (45%). Four patients had developed complications (minimal
reduction in MIO) related to the donor site.
Conclusion: Donor site morbidity associated with buccinator-based myomucosal flaps is low.
However, minimal reduction of mouth opening occurred in 20% of the patients.
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Buccinator-based myomucosal flaps can be used as a lining
in oral cavity, pharyngeal, esophageal, and nasal
reconstructions.1e4 The mucosal surface is better than skin
for reconstruction of mucosal defects in these regions.
Buccinator-based myomucosal flaps are thin flaps with the
ability to secrete saliva; therefore, they are optimal foror site morbidity in buccinator-based myomucosal flaps: A retro-
1016/j.asjsur.2015.10.010
lsevier Taiwan LLC. All rights reserved.
Table 1 Demographic data of the patients in which variants of buccinator-based myomucosal flaps were used for oral, nasal,
and oropharyngeal reconstruction.
No. Age (y) Sex Type of
buccinator-based
flap used
Flap size
(cm)
Diagnosis/defect Complication Donor site
closure
Follow
up (y)
Radiotherapy
1 12 M FAMM (Sup based) 2.5  4 Edentulous atrophic
Premaxilla
d DC 3 d
2 22 F Posterior BUMIF
(Bilateral)
3.5  4
3.5  4
Palatal fistula Limitation in MIO
(32 mm)
BFP 3 d
3 14 M FAMM (Sup based) 2.5  4 Unilateral wide AC d DC 1 d
4 35 F FAMM (Sup based) 1.5  3 Anterior mandibular
vestibule
d DC 1 d
5 40 F Inf BUMIF 5  5 Tongue SCC Limitation in MIO
(31 mm)
BFP 4 þ
6 18 F FAMM (Sup based) 2.5  4 Edentulous atrophic
Premaxilla
d DC 3 d
7 87 M Inf BUMIF 4.5  4.5 Floor of mouth SCC d BFP 2 þ
8 13 F Pribaz flap 2  4 Palatal schwannoma d DC 4 d
9 70 M FAMM (Inf based) 2  4.5 Mandibular vestibule
(Trauma)
d DC 1 d
10 60 M Pribaz flap 2.5  5 Traumatic palatal
fistula
d DC 2 d
11 18 M FAMM (Sup based) 2  5 Nasal lining (Trauma) d DC 1 d
12 15 F FAMM (Sup based) 2.5  4 Edentulous atrophic
Premaxilla
Limitation in MIO
(32 mm)
DC 2 d
13 35 M Sup BUMIF 3  4 Large palatal fistula d Masseter
flap
2 d
14 45 M Inf BUMIF 4  4 Oropharynx
(Adenoid cystic
carcinoma)
d BFP 2 þ
15 25 F FAMM (Sup based) 2.5  4 Edentulous atrophic
Premaxilla
d DC 2 d
16 62 M Inf BUMIF 4  5 Contra lateral
mandibular vestibule
(Ameloblastoma)
d BFP 1 d
17 68 M Anteriorly based 1.5  5 Lower lip vermilion
(SCC)
d DC 2 d
18 18 F FAMM (Sup based) 3.5  5 Large palatal fistula Limitation in MIO
(33 mm)
BFP 2 d
19 22 F FAMM (Sup based) 3.5  4 Large palatal fistula d BFP 1 d
20 35 M FAMM (Sup based)
bilateral
2.5  4 Anterior maxillary
melanoma
d DC 4 þ
AC Z alveolar cleft; BFP Z buccal fat pad; BUMIF Z buccinator based myomucosal island flap; DC Z direct closure; F Z female;
FAMMZ facial artery myomucosal flap; InfZ inferior; MZmale; MIOZmaximal interincisal opening; SCCZ squamous cell carcinoma;
Sup Z superior.
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These flaps are arterialized, based on the facial or maxil-
lary arteries, which makes them very reliable. Donor site
morbidity is an important factor to consider when selecting
a flap; therefore, a decision was made to evaluate donor
site morbidity in this group of flaps.2. Materials and method
In a retrospective study, patients for whom this flap had
been used for oral, nasal, or pharyngeal reconstruction in
2008e2012 were recalled. All the patients had beenPlease cite this article in press as: Rahpeyma A, Khajehahmadi S, Don
spective study, Asian Journal of Surgery (2015), http://dx.doi.org/10.operated on by the same surgeon. Donor site morbidity
including reduction in maximal interincisal opening (MIO),
obliteration of the mandibular vestibule, injury to the
Stensen duct, and vertical fibrous band in buccal mucosa
were evaluated. Limitations in mouth opening were recor-
ded as a decrease in MIO and classified based on the sug-
gestion of Thomas et al6: severe (MIO < 15 mm), moderate
(15 mm < MIO < 30 mm), minimal (30 mm < MIO < 35 mm),
and no limitation in mouth opening when MIO was >35 mm.
In edentulous patients the same measurements were
made while removable complete dentures were in the
mouth.or site morbidity in buccinator-based myomucosal flaps: A retro-
1016/j.asjsur.2015.10.010
Figure 1 (A) Vertical scar band in buccal mucosa.
(B) Multiple z-plasty flaps. (C) Result 3 months after
operation.
Figure 2 (A) Obliteration of the mandibular vestibule. (B)
Alloderm is used for covering the raw surface of the deepened
buccal vestibule.
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Anterior incision was considered 1 cm behind the oral
commissure. In Facial Artery Musculomucosal (FAMM) flaps
the boundary of the flap was chosen anterior to the Stensen
duct, however, in BUMIF (buccinator-based myomucosal
island flap) flaps, superior incision was designed below the
opening of the parotid salivary gland. Inferiorly based FAMM
and BUMIF flaps followed the course of the facial artery.
The paddle long axis was vertical in FAMM flaps, whereas it
was horizontal in posteriorly-based buccinator myomucosal
flaps. The paddle of inferiorly based BUMIF flaps has near-
equal length and width.Please cite this article in press as: Rahpeyma A, Khajehahmadi S, Don
spective study, Asian Journal of Surgery (2015), http://dx.doi.org/10.3. Results
Table 1 shows demographic data of the patients who
received a buccinator-based myomucosal flap for oral,
nasal, or oropharyngeal reconstruction. In total, 22
buccinator-based myomucosal flaps (20 patients) were used
for oral, nasal, and oropharyngeal reconstruction. Variants
of this flap were mostly used for oral cavity reconstruction
(90%). The mean age of the patients was 35.7 2.25 years,
with a male/female ratio of 11; 9. Various forms of these
flaps were used including: FAMM flap (superiorly or inferi-
orly pedicled), posteriorly based flap (Pribaz flap), BUMIF,
and finally the anteriorly based flap. The most commonly
used flap was the FAMM flap (50%), and the commonest
indication for flap use was late sequelae of cleft lip/palate
repair (45%).Other usage in our series included treatment of
neoplastic lesions or malignant lesions (35%), and traumatic
events (20%). Four patients experienced postoperative
radiotherapy, and minimum follow up was 1 year. The donor
site had been closed by direct closure in 59% of events.
Buccal fat pad mobilization had been used to cover the
donor site in 36% of cases. In one case, it had proved
impossible to herniate the buccal fat pad into the surgical
field; as a result, the superiorly based masseter muscle flapor site morbidity in buccinator-based myomucosal flaps: A retro-
1016/j.asjsur.2015.10.010
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between direct closure and buccal fat pad mobilization to
manage donor site was done according to Ferrari et al7
recommendations. Donor sites (width  3 cm) were
covered by buccal fat pads.7
Four patients developed complications (minimal reduc-
tion in MIO) related to the donor site. In one patient, a
vertical mucosal band in the line of primary closure of the
superiorly based FAMM flap occurred, and was overcome by
a multiple z plasty. It was the same case in which the donor
site had been managed by direct approximation (Figure 1).
In another patient, the obliteration of the mandibular
buccal vestibule and tight tissue in the donor site (buccal)
caused complications; vestibuloplasty with the aid of allo-
derm was used to solve this problem (Figure 2). Two other
patients, who had buccal mucosal scarring, did not agree to
further surgical intervention (Figure 3).4. Discussion
Buccinator-based myomucosal flaps are axial-pattern flaps.
Structurally, these flaps contain buccal mucosa, part of the
buccinator muscle in full thickness, and an axial vessel. If
the nourishing vessel is the buccal branch of the maxillary
artery, the flap is called the posteriorly based flap. In the
other variants, the dominant nutrient vessels are the facial
artery and vein.
The donor site in FAMM flaps is closed by primary closure
if the width of the defect is considered <2.5 cm.8 In largerFigure 3 Scar in buccal mucosa related to the superiorly-
based FAMM flap. (A) Left side. (B) Right side. FAMM, facial
artery musculomucosal.
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lizing the buccal fat pad.9
In Ferrari et al’s10 research on donor site morbidity of
buccinator-based myomucosal flaps in 15 patients, no
complications were reported. However, in our series, the
rate of donor site complications was 20% with minimum
limitation in mouth opening. Despite the fact that primary
direct closure was the most commonly used method for
management of the donor site, the complication rate was
lower (8%) in comparison with the buccal fat pad group
(43%). This shows the fact that if more mucosa is harvested,
the complications will increase. It is accepted that post-
operative radiotherapy with the masticatory muscles in the
field of radiation has a negative effect in mouth opening.11
In the present study, four patients had such condition and
only one of them experienced a decrease in MIO. In this
case, MIO limitation occurs before the radiotherapy. Post-
operative radiotherapy may have a cumulative negative
effect on mouth opening. There was no case of sialocele
formation due to Stensen duct injury. This fact showed that
the surgeon strictly adhered to the principles of FAMM flap
elevation. The location of the paddle in the FAMM flap was
anterior to the Stensen duct and in the island variants su-
perior incision was performed 2e5 mm bellow the parotid
duct opening.12,13
Obliteration of the mandibular vestibule indicated that
the surgeon had harvested the mucosa using inferior inci-
sion to the depth of the lower vestibule. Therefore, when
the defect is covered by the buccal fat pad, the wound
contracture during the secondary epithelialization process
leads to obliteration of the vestibule. To prevent this
problem, the suggested technique involves retaining the
mandibular vestibular mucosa while the underlying bucci-
nator muscle is included in the flap.Using this strategy, the
maximum paddle size is obtained and the mandibular
vestibular depth remains undisturbed.
In one patient, it was not possible to herniate the buccal
fat pad into the surgical field after incising the bucco-
pharyngeal fascia. This might occur in thin-faced patients,
and the surgeon should have an alternative plan to solve
this problem. In such cases the masseter muscle flap is a
good option.14
5. Conclusion
Donor site morbidity related to buccinator-based myomu-
cosal flaps is low. However, minimal reduction of mouth
opening occurred in 20% of patients.
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